biotechnology - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

News

Novartis and Ratio Enter Radiotherapeutics Partnership Worth $745m

Novartis and Ratio Therapeutics have entered into a worldwide licence and collaboration agreement worth $745m to advance a somatostatin receptor 2 (SSTR2)-targeting ...

27 November 2024 News biotechnology | drug

Continue Reading →

Volume 15 Issue 3

A New Age of Pharmaceutical Innovation

IPI Speaks with Dr Patrick Larcier, Senior Director, Strategy Product Development Solutions, EU & US, of PharmaLex, on Next-generation Small Molecules Q: Can ...

29 September 2023 Volume 15 Issue 3 Age | biotechnology

Continue Reading →

Volume 15 Issue 2

The Future of AI in Biotechnology

On the Precipice of the New Technological Revolution The artificial intelligence revolution kicked into high gear seemingly overnight. Generative AI platforms lik...

3 July 2023 Volume 15 Issue 2 AI | artificial

Continue Reading →

Volume 15 Issue 1

Into the Future with Next-generation Small Molecules

Heightened interest in small molecules is likely to continue in 2023 and beyond as several biotech companies look beyond biologics to bring medicines to patients in ...

4 April 2023 Volume 15 Issue 1 biotechnology | Innovations

Continue Reading →

News

BIOCAD launches the new manufacturing site in North Africa

Russian biotechnology company BIOCAD and Moroccan pharmaceutical company Sothema Labs announced the launch of medicines derived using the technology provided by the ...

29 November 2017 News biosimilars | biotechnology

Continue Reading →

News

Locus Biosciences raises $19 million series A for CRISPR-Cas3 Antimicrobials

Locus Biosciences has closed $19 million in Series A funding led by venture capital firm ARTIS Ventures with additional financing from notable institutional investor...

17 November 2017 News antibiotic | antimicrobial

Continue Reading →

News

Poor aggregation will see ADC targets fail or face long delays

ADC Biotechnology (ADC Bio)‘s leading experts warn that best in class ADCs are being overlooked due to critical aggregation control problems. CDMOs are unable to dev...

14 November 2017 News ADC | biotechnology

Continue Reading →